Rapid Tech Transfer of Vaccine Drug Substance
Amid the COVID-19 pandemic, Emendo drove a rapid pharma tech transfer of a vaccine drug substance from Phase 2 to Phase 3 manufacturing for a BioTech client. The project was conducted under time pressure, global supply chain disruptions, and pharma regulatory compliance requirements.















